Vendor review
Huayi Biotechnology reviews
Huayi Biotechnology reviews from 47 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Huayi Biotechnology legit? See what its vials showed.
Grade A47 independent lab tests0 peptides listedShips from China
Huayi Biotechnology's website could not be reached at the last check. Links to the shop are disabled.
What the lab tests show
47 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 6, 2026 | GHK-Cu | 99.7 % | 57.9 mg of 50 mg (16 %) | Pass | View |
| Oct 6, 2026 | BPC-157 | 99.6 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.99 % | 32.01 mg of 30 mg (7 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 93.7 mg of 100 mg (-6 %) | Pass | View |
| Sep 8, 2026 | Retatrutide | 99.9 % | 36.2 mg of 30 mg (21 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 9.3 mg of 10 mg (-7 %) | Pass | View |
| Jun 15, 2026 | Tirzepatide | 99.9 % | 13.2 mg of 15 mg (-12 %) | Pass | View |
| Jun 12, 2026 | Retatrutide | 99.9 % | 46.6 mg of 50 mg (-7 %) | Pass | View |
| Jun 6, 2026 | Retatrutide | 99.8 % | 21.8 mg of 20 mg (9 %) | Pass | View |
| Jun 6, 2026 | Retatrutide | 20 mg | View | ||
| May 8, 2026 | Retatrutide | 99.9 % | 17.7 mg of 20 mg (-12 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 18.1 mg of 20 mg (-10 %) | Pass | View |
| Apr 23, 2026 | GHK-Cu | 99.9 % | 43.1 mg of 50 mg (-14 %) | Pass | View |
| Mar 29, 2026 | Retatrutide | 99.8 % | 30 mg of 30 mg (0 %) | Pass | View |
| Mar 18, 2026 | Tirzepatide | 99.9 % | 10 mg of 10 mg (0 %) | Pass | View |
| Mar 18, 2026 | GHK-Cu | 99.9 % | 41.2 mg of 50 mg (-18 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 16, 2026 | Retatrutide | 99.9 % | 4.94 mg of 5 mg (-1 %) | Pass | View |
| Mar 10, 2026 | GHK-Cu | 99.63 % | 74.9 mg of 100 mg (-25 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.9 % | 90.8 mg of 100 mg (-9 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.5 % | 22.5 mg of 20 mg (13 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.9 % | 61.4 mg of 50 mg (23 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.8 % | 9.5 mg of 10 mg (-5 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.65 % | 32.2 mg of 30 mg (7 %) | Pass | View |
| Feb 18, 2026 | BPC-157 | 99.03 % | 5.31 mg of 5 mg (6 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Feb 11, 2026 | Tirzepatide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 11, 2026 | GHK-Cu | 99.9 % | 49.2 mg of 50 mg (-2 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Feb 2, 2026 | BPC-157 | 99.9 % | 9.01 mg of 10 mg (-10 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.9 % | 35.1 mg of 30 mg (17 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.8 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.95 % | 9.98 mg of 10 mg (0 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.5 % | 5.3 mg of 5 mg (6 %) | Pass | View |
| Jan 6, 2026 | GHK-Cu | 99.95 % | 115 mg of 100 mg (15 %) | Pass | View |
| Oct 21, 2025 | Retatrutide | 99.4 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Oct 9, 2025 | Retatrutide | 99.83 % | 29.7 mg of 30 mg (-1 %) | Pass | View |
| Oct 9, 2025 | Retatrutide | 99.26 % | 14.9 mg of 15 mg (-1 %) | Pass | View |
| Sep 30, 2025 | Retatrutide | 99.95 % | 9.28 mg of 10 mg (-7 %) | Pass | View |
| Sep 25, 2025 | BPC-157 | 99.91 % | 5.01 mg of 5 mg (0 %) | Pass | View |
| Sep 18, 2025 | Tirzepatide | 99.93 % | 11.6 mg of 15 mg (-23 %) | Pass | View |
| Sep 18, 2025 | BPC-157 | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Sep 9, 2025 | Retatrutide | 99.72 % | 12.73 mg of 10 mg (27 %) | Pass | View |
| Sep 4, 2025 | Tirzepatide | 99.91 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 4, 2025 | Retatrutide | 99.95 % | 21.7 mg of 20 mg (9 %) | Pass | View |
| Sep 1, 2025 | Retatrutide | 99.83 % | 22.48 mg of 20 mg (12 %) | Pass | View |
| Sep 1, 2025 | Tirzepatide | 99.86 % | 21.02 mg of 20 mg (5 %) | Pass | View |
What Huayi Biotechnology sells
No current listings on record.
About Huayi Biotechnology
Finnrick has tested 47 samples from Huayi Biotechnology across 4 products.